Thyroid eye disease (TED) is an inflammatory disease of the eye and the surrounding tissues. The inflammation is due to an autoimmune reaction - the body's immune system is attacking tissues within and around the eye socket. TED is sometimes referred to by other names, such as Graves' ophthalmopathy, Graves' orbitopathy, thyroid-associated ophthalmopathy, and/or thyroid orbitopathy.
Differential Diagnosis When examining a patient with suspected TED, it is important to have a working differential. The following diagnoses share some similarities to the clinical presentation of TED Allergic conjunctivitis – While both can cause excess tearing and conjunctivitis, allergic conjunctivitis tends to be acute in onset from a new exposure, causes itching, can have papillary ...
TED is a self-limiting disease, with patients moving from the active to quiescent phase within 1-3 years with a 5-10% risk of recurrence [10]. Treatment for TED should start at the time of the diagnosis, as treatment becomes less effective as the disease progresses from the early, acute, active phase to the chronic quiescent phase.
Thyroid eye disease (TED) is an autoimmune inflammatory disease of the eye and surrounding associated with tyroid disease or dysfunction. The most common presenting signs are orbital and periorbital edema, eyelid retraction, eyelid lag in downgaze, restrictive strabismus, compressive optic neuropathy, and exposure keratopathy.
Thyroid eye disease (TED) is the most common cause of unilateral or bilateral proptosis in adults. It occurs most commonly in patients who are hyperthyroid. However, it may also occur in patients who are hypothyroid or even euthyroid.